Pluristem Therapeutics increases bought deal By: MarketMinute.com Stock News January 20, 2017 at 16:14 PM EST Pluristem Therapeutics Inc. (Nasdaq: PSTI) increased its previously announced bought deal to $15 million. The stock price fell 25 cents to close at $1.15. Related Stocks: Pluristem Therapeutc